Natural killer cell therapy is a type of cellular immunotherapy, just like CAR T-cell therapy. Like T-cells, NK cells form part of the immune system and attack germs and other malignant cells. Unlike T-cells, however, NK cells are not tailored to specific antigens.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
NK Cell Therapies
NK Cell Directed Antibodies
Market Segment by Product Application
Cancer
Gastrointestinal Diseases
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Nektar Therapeutics
Innate
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Natural Killer Cell Therapies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Natural Killer Cell Therapies market by identifying its various subsegments.
3.Focuses on the key global Natural Killer Cell Therapies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Natural Killer Cell Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Natural Killer Cell Therapies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Natural Killer Cell Therapies Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Natural Killer Cell Therapies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Natural Killer Cell Therapies Segment by Type
2.1.1 NK Cell Therapies
2.1.2 NK Cell Directed Antibodies
2.2 Market Analysis by Application
2.2.1 Cancer
2.2.2 Gastrointestinal Diseases
2.2.3 Others
2.3 Global Natural Killer Cell Therapies Market Comparison by Regions (2017-2027)
2.3.1 Global Natural Killer Cell Therapies Market Size (2017-2027)
2.3.2 North America Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.3 Europe Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.4 China Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.5 Japan Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.6 Southeast Asia Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Natural Killer Cell Therapies Industry Impact
2.5.1 Natural Killer Cell Therapies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Natural Killer Cell Therapies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Natural Killer Cell Therapies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Natural Killer Cell Therapies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Natural Killer Cell Therapies Manufacturer Market Share
3.5 Top 10 Natural Killer Cell Therapies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
3.7 Key Manufacturers Natural Killer Cell Therapies Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Natural Killer Cell Therapies Industry Key Manufacturers
4.1 Nektar Therapeutics
4.1.1 Compan Detail
4.1.2 Nektar Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.1.3 Nektar Therapeutics 163 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Nektar Therapeutics News
4.2 Innate
4.2.1 Compan Detail
4.2.2 Innate Natural Killer Cell Therapies Product Introduction, Application and Specification
4.2.3 Innate Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Nektar Therapeutics News
4.3 Affimed
4.3.1 Compan Detail
4.3.2 Affimed Natural Killer Cell Therapies Product Introduction, Application and Specification
4.3.3 Affimed Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Affimed News
4.4 Chipscreen Biosciences
4.4.1 Compan Detail
4.4.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Introduction, Application and Specification
4.4.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Chipscreen Biosciences News
4.5 Fate Therapeutics
4.5.1 Compan Detail
4.5.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Introduction, Application and Specification
4.5.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Fate Therapeutics News
4.6 Glycostem
4.6.1 Compan Detail
4.6.2 Glycostem Natural Killer Cell Therapies Product Introduction, Application and Specification
4.6.3 Glycostem Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Glycostem News
4.7 Dragonfly Therapeutics
4.7.1 Compan Detail
4.7.2 Dragonfly Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.7.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Kiadis Pharma
4.8.1 Compan Detail
4.8.2 Kiadis Pharma Natural Killer Cell Therapies Product Introduction, Application and Specification
4.8.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Kiadis Pharma News
4.9 NantWorks
4.9.1 Compan Detail
4.9.2 NantWorks Natural Killer Cell Therapies Product Introduction, Application and Specification
4.9.3 NantWorks Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 NantWorks News
4.10 Nkarta Therapeutics
4.10.1 Compan Detail
4.10.2 Nkarta Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.10.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Nkarta Therapeutics News
4.11 Fortress Biotech
4.11.1 Compan Detail
4.11.2 Fortress Biotech Natural Killer Cell Therapies Product Introduction, Application and Specification
4.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Fortress Biotech News
5 Global Natural Killer Cell Therapies Market Segment by Big Type
5.1 Global Natural Killer Cell Therapies Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Big Type (2017-2022)
5.2 NK Cell Therapies Sales Growth Rate and Price
5.2.1 Global NK Cell Therapies Sales Growth Rate (2017-2022)
5.2.2 Global NK Cell Therapies Price (2017-2022)
5.3 NK Cell Directed Antibodies Sales Growth Rate and Price
5.3.1 Global NK Cell Directed Antibodies Sales Growth Rate (2017-2022)
5.3.2 Global NK Cell Directed Antibodies Price (2017-2022)
6 Global Natural Killer Cell Therapies Market Segment by Big Application
6.1 Global Natural Killer Cell Therapies Sales Market Share by Big Application (2017-2022)
6.2 Cancer Sales Growth Rate (2017-2022)
6.3 Gastrointestinal Diseases Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Natural Killer Cell Therapies Forecast
7.1 Global Natural Killer Cell Therapies Revenue, Sales and Growth Rate (2022-2027)
7.2 Natural Killer Cell Therapies Market Forecast by Regions (2022-2027)
7.2.1 North America Natural Killer Cell Therapies Market Forecast (2022-2027)
7.2.2 Europe Natural Killer Cell Therapies Market Forecast (2022-2027)
7.2.3 China Natural Killer Cell Therapies Market Forecast (2022-2027)
7.2.4 Japan Natural Killer Cell Therapies Market Forecast (2022-2027)
7.2.5 Southeast Asia Natural Killer Cell Therapies Market Forecast (2022-2027)
7.2.6 Other Regions Natural Killer Cell Therapies Market Forecast (2022-2027)
7.3 Natural Killer Cell Therapies Market Forecast by Type (2022-2027)
7.3.1 Global Natural Killer Cell Therapies Sales Forecast by Type (2022-2027)
7.3.2 Global Natural Killer Cell Therapies Market Share Forecast by Type (2022-2027)
7.4 Natural Killer Cell Therapies Market Forecast by Application (2022-2027)
7.4.1 Global Natural Killer Cell Therapies Sales Forecast by Application (2022-2027)
7.4.2 Global Natural Killer Cell Therapies Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Natural Killer Cell Therapies Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Natural Killer Cell Therapies Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Natural Killer Cell Therapies
Figure Market Concentration Ratio and Market Maturity Analysis of Natural Killer Cell Therapies
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Natural Killer Cell Therapies Market Size by Big Type
Figure Global Market Share of Natural Killer Cell Therapies by Big Type in 2021
Figure NK Cell Therapies Picture (2017-2022)
Global Natural Killer Cell Therapies Market Size by Big Application
Table Global Natural Killer Cell Therapies Market Size by Application
Figure Global Natural Killer Cell Therapies Market Share by Big Application in 2021
Figure Cancer Picture
Figure Gastrointestinal Diseases Picture
Figure Others Picture
Table Global Natural Killer Cell Therapies Comparison by Regions (M USD) (2017-2027)
Figure Global Natural Killer Cell Therapies Market Size (Million US$) (2017-2027)
Figure North America Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure China Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Natural Killer Cell Therapies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Natural Killer Cell Therapies Sales by Manufacturer (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Manufacturer in 2021
Table Global Natural Killer Cell Therapies Revenue by Manufacturer (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Manufacturer in 2021
Table Global Natural Killer Cell Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Natural Killer Cell Therapies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Natural Killer Cell Therapies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
Table Key Manufacturers Natural Killer Cell Therapies Product Type
Table Mergers & Acquisitions Planning
Table Nektar Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Nektar Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Innate Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Innate
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Innate Recent Development
Table Affimed Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Affimed
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Affimed Main Business
Table Affimed Recent Development
Table Chipscreen Biosciences Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Chipscreen Biosciences
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Chipscreen Biosciences Main Business
Table Chipscreen Biosciences Recent Development
Table Chipscreen Biosciences Main Business
Table Chipscreen Biosciences Recent Development
Table Fate Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Fate Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fate Therapeutics Main Business
Table Fate Therapeutics Recent Development
Table Glycostem Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Glycostem
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glycostem Main Business
Table Glycostem Recent Development
Table Dragonfly Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Dragonfly Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dragonfly Therapeutics Main Business
Table Dragonfly Therapeutics Recent Development
Table Kiadis Pharma Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Kiadis Pharma
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kiadis Pharma Main Business
Table Kiadis Pharma Recent Development
Table NantWorks Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of NantWorks
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table NantWorks Main Business
Table NantWorks Recent Development
Table Nkarta Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Nkarta Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Nkarta Therapeutics Main Business
Table Nkarta Therapeutics Recent Development
Table Fortress Biotech Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Fortress Biotech
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fortress Biotech Main Business
Table Fortress Biotech Recent Development
Figure Global Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Regions (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Regions in 2021
Table Global Natural Killer Cell Therapies Revenue by Regions (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Regions in 2021
Figure North America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Europe Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure China Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Japan Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Other Regions Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Big Type (2017-2022)
Table Global Natural Killer Cell Therapies Sales Market Share by Big Type (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Big Type in 2019
Table Global Natural Killer Cell Therapies Revenue by Big Type (2017-2022)
Table Global Natural Killer Cell Therapies Revenue Market Share by Big Type (2017-2022)
Table Global Natural Killer Cell Therapies Revenue Market Share by Big Type in 2019
Figure Global NK Cell Therapies Sales Growth Rate (2017-2022)
Figure Global NK Cell Therapies Price (2017-2022)
Figure Global NK Cell Directed Antibodies Sales Growth Rate (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Big Application (2017-2022)
Table Global Natural Killer Cell Therapies Sales Market Share by Big Application (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Big Application in 2019
Figure Global Cancer Sales Growth Rate (2017-2022)
Figure Global Gastrointestinal Diseases Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Natural Killer Cell Therapies Sales and Growth Rate (2022-2027)
Figure Global Natural Killer Cell Therapies Revenue and Growth Rate (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Regions (2022-2027)
Table Global Natural Killer Cell Therapies Market Share Forecast by Regions (2022-2027)
Figure North America Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Europe Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure China Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Japan Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Southeast Asia Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Other Regions Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Type (2022-2027)
Table Global Natural Killer Cell Therapies Market Share Forecast by Type (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Application (2022-2027)
Table Global Natural Killer Cell Therapies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Natural Killer Cell Therapies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Natural Killer Cell Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Natural Killer Cell Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Natural Killer Cell Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Natural Killer Cell Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Natural Killer Cell Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Natural Killer Cell Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Natural Killer Cell Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Natural Killer Cell Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Nektar Therapeutics
Innate
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem
Dragonfly Therapeutics
Kiadis Pharma
NantWorks